Clinical Trials
17 trialsNCT07597252 2026-05-19
K4CARE-PDAC
Chang Gung Memorial Hospital
Not yet recruiting
NCT07524114 2026-05-11
SHERLOCK
University Health Network, Toronto
Recruiting
NCT06111105 2026-05-04
GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
University of Aarhus
Recruiting
NCT07454486 2026-03-06
TRACE-BTC
Aarhus University Hospital
Not yet recruiting
NCT06287814 2025-07-10
French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)
University Hospital, Montpellier
Recruiting
NCT05196087 2025-07-02
NIP IT!
University Health Network, Toronto
Recruiting
NCT06449846 2024-06-10
Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma
Zhujiang Hospital
Not yet recruiting
NCT06404593 2024-05-08
Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases
Peking University Cancer Hospital & Institute
Completed
NCT05219734 2024-03-12
MARIA
Invitae Corporation
Active not recruiting
NCT06287723 2024-03-01
French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)
University Hospital, Montpellier
Not yet recruiting
NCT05371873 2023-09-13
A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer
First Affiliated Hospital of Zhejiang University
Unknown
NCT05969938 2023-08-01
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology
Sun Yat-sen University
Unknown
NCT05952661 2023-07-19
ECMRD-001
Hebei Medical University Fourth Hospital
Recruiting
NCT05900583 2023-06-12
Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.
Guangdong Provincial People's Hospital
Unknown
NCT05867901 2023-05-31
Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence
Peking University People's Hospital
Recruiting
NCT05743959 2023-05-22
ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers:A Multicenter Prospective Trial
The First Affiliated Hospital with Nanjing Medical University
Unknown
NCT05408897 2022-09-21
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
Peking University People's Hospital
Recruiting